Law & Policy

·

Policy

Canada Grants Far More Psychedelic Therapy Access Than the U.S.

Canada Grants Far More Psychedelic Therapy Access Than the U.S.

Psilocybin mushrooms

What they found

Canada approved psilocybin or MDMA for 200+ patients in two years, versus about 50 in the U.S. since 2020.

Canada approved psilocybin or MDMA for 200+ patients in two years, versus about 50 in the U.S. since 2020.

The number

200+ patients in two years

How solid is it?

n/a

n/a

Not a study

Not a study

Evidence ladder: Lab dish → Animal → Early human → Strong human. Reviews summarize earlier research.

At a glance

Latin name

Compound

psilocybin; MDMA

psilocybin; MDMA

Published in

gpsych.bmj.com

gpsych.bmj.com

Covered in Shroom Scan

Section

PSILOCYBIN & LEGISLATION

PSILOCYBIN & LEGISLATION

As it ran in Shroom Scan

Access in the U.S. Vs. Canada

Access in the U.S. Vs. Canada

Canada has approved psilocybin or MDMA for 200+ patients in two years, while the U.S. has granted access to only 50 patients since 2020, with treatments limited to 10 sites.

Canada has approved psilocybin or MDMA for 200+ patients in two years, while the U.S. has granted access to only 50 patients since 2020, with treatments limited to 10 sites.

Blood Pressure Research, Fungal Antibiotics, and Psilocybin for Autism

Read the original study ↗

Get Shroom Scan

Next study

Ex-ABC Anchor Kendis Gibson on Psilocybin Reshaping His Outlook ›

Shroom Scan · Every Friday

Get Studies Like This, Translated, Every Week

Ten new studies a week, each boiled down to what it found and why it matters to you. Free, and one click to leave.

See what's inside →